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Background/aims: As a module of a standard ultrasound imaging device, acoustic
radiation force impulse (ARFI) is a new technology for liver stiffness evaluation
(LSE). We aimed to evaluate accuracy, feasibility, reproducibility, and training effect
of ARFI for liver fibrosis evaluation.Methods: One hundred and one patients with
chronic liver disease had LSE by Fibroscan and ARFI. LSE by ARFI was performed in
the two liver lobes by two operators: an expert and a novice. Correlation and
agreement were evaluated by the Pearson (Rp) and intraclass (Ric) correlation
coefficients. The independent reference for liver fibrosis was fibrosis blood tests.
Results: ARFI results, ranging from 0.7 to 4.6 m/s, were well correlated with
Fibroscan results (Rp=0.76). Fibroscan had a significantly higher area under the
receiver operating characteristic curve (AUROC) than ARFI for the perprotocol
diagnosis of significant fibrosis: 0.890±0.034 versus 0.795±0.047 (P=0.04).
However, LSE failure occurred in zero patients using ARFI versus six patients using
Fibroscan (P=0.03). Thus, on an intention-to-diagnose basis, Fibroscan and ARFI
AUROCs for the diagnosis of significant fibrosis were not different: 0.791±0.049
versus 0.793±0.046 (P=0.98). Interobserver agreement was very good (Ric=0.84)
and excellent for ARFI interquartile range (IQR)≤0.30 (Ric=0.91). Indeed, agreement
was independently predicted only by ARFI IQR, but not by LSE result as earlier
observed for Fibroscan. ARFI AUROC was 0.876±0.057 in patients with ARFI IQR
ratio≤0.30, and Fibroscan AUROC was 0.912±0.034 in patients with Fibroscan IQR
ratio less than 0.21 (P=0.59). Intersite ARFI agreement between the two liver lobes
was fair (Ric=0.60). There was no training effect for LSE by ARFI. Conclusion: ARFI
is highly feasible and reproducible, and provides diagnostic accuracy similar to
Fibroscan. This new device seems noteworthy for the widespread noninvasive
diagnosis of liver fibrosis.
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